Allogene Therapeutics, Inc.

Bank of New York Mellon Corp ALLO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

405,843

Value ($000)

556

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	556	0.0%	405,843	12/31/2025
2025 Q3	11/3/2025	498	0.0%	401,871	9/30/2025
2025 Q2	8/5/2025	424	0.0%	375,037	6/30/2025
2025 Q1	4/29/2025	484	0.0%	331,192	3/31/2025
2024 Q4	2/4/2025	705	0.0%	330,769	12/31/2024
2024 Q3	11/12/2024	889	0.0%	317,619	9/30/2024
2024 Q2	7/25/2024	844	0.0%	362,364	6/30/2024
2024 Q1	4/25/2024	1,343	0.0%	300,553	3/31/2024
2023 Q4	1/29/2024	1,040	0.0%	323,981	12/31/2023
2023 Q3	10/24/2023	985	0.0%	310,814	9/30/2023
2023 Q2	8/3/2023	1,535	0.0%	308,886	6/30/2023
2023 Q1	5/9/2023	1,730	0.0%	350,169	3/31/2023
2022 Q4	2/14/2023	1,940	0.0%	308,422	12/31/2022
2022 Q3	11/14/2022	3,115	0.0%	288,522	9/30/2022
2022 Q2	8/15/2022	2,831	0.0%	248,381	6/30/2022
2022 Q1	5/11/2022	2,726	0.0%	299,247	3/31/2022
2021 Q4	2/11/2022	4,456	0.0%	298,678	12/31/2021
2021 Q3	11/18/2021	8,193	0.0%	318,805	9/30/2021
2021 Q2	8/11/2021	7,363	0.0%	282,337	6/30/2021
2021 Q1	5/13/2021	7,841	0.0%	222,150	3/31/2021
2020 Q4	2/9/2021	5,810	0.0%	230,166	12/31/2020
2020 Q3	11/12/2020	8,417	0.0%	223,219	9/30/2020
2020 Q2	8/12/2020	9,777	0.0%	228,329	6/30/2020
2020 Q1	5/6/2020	3,084	0.0%	158,666	3/31/2020
2019 Q4	2/14/2020	4,068	0.0%	156,590	12/31/2019